de en
  • Paion GmbH
  • Company

    About PAION

    1. History
    2. Management
    3. Supervisory Board

    Information

    1. Events
    2. Information Request
  • Products

    Remimazolam

    1. About Remimazolam
    2. UK SMPC for remimazolam
    3. UK PIL for remimazolam

    Angiotensin II

    1. About Angiotensin II

    Eravacycline

    1. About eravacycline
  • Career

    What does PAIONeering mean to us?

    What PAIONeers can expect

    1. Professional Development

    Job offers

  • Media and Investors

    At a glance

    1. General Information
    2. Contact

    Newsroom

    1. Press Releases
    2. Ad-hoc Releases
    3. Directors' Dealings
    4. Holdings in company

    Information on shares

    1. Chart & Fact sheet
    2. Analysts
    3. Capital actions
    4. Information on CeNeS Acquisition

    Investorcenter

    1. Financial Reports
    2. Presentations
    3. Corporate calendar
    4. Information Request

    Corporate Governance

    1. Declaration on Corporate Governance
    2. Articles of Association
    3. Declaration of Conformity
    4. Code of Conduct
    5. By-Laws Supervisory Board
    6. Compensation Management Board and Supervisory Board

    Annual general meeting

    2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
  • Contact

    Germany

    UK

    Nordic Countries

    Netherlands

prev next
  • Media and Investors  » 
  • Investorcenter  » 
  • Presentations  » 
  • 2022
  • 03/30/2022

    Presentation Annual Financial Results 2021

    • PDF

  • copyright © PAION AG I all rights reserved
  • Imprint
  • Privacy Statement
  • General Terms and Conditions
Paion

Heussstraße 25 | 52078 Aachen | Deutschland

Tel.: +49 241 4453-0 | Fax.: +49 241 4453-100 | e-mail: info@paion.com

Company
  1. About PAION +
    1. History
    2. Management
    3. Supervisory Board
  2. Information +
    1. Events
    2. Information Request
Products
  1. Remimazolam +
    1. About Remimazolam
    2. UK SMPC for remimazolam
    3. UK PIL for remimazolam
  2. Angiotensin II +
    1. About Angiotensin II
  3. Eravacycline +
    1. About eravacycline
Career
  1. What does PAIONeering mean to us?
  2. What PAIONeers can expect +
    1. Professional Development
  3. Job offers
Media and Investors
  1. At a glance +
    1. General Information
    2. Contact
  2. Newsroom +
    1. Press Releases
    2. Ad-hoc Releases
    3. Directors' Dealings
    4. Holdings in company
  3. Information on shares +
    1. Chart & Fact sheet
    2. Analysts
    3. Capital actions
    4. Information on CeNeS Acquisition
  4. Investorcenter +
    1. Financial Reports
    2. Presentations
    3. Corporate calendar
    4. Information Request
  5. Corporate Governance +
    1. Declaration on Corporate Governance
    2. Articles of Association
    3. Declaration of Conformity
    4. Code of Conduct
    5. By-Laws Supervisory Board
    6. Compensation Management Board and Supervisory Board
  6. Annual general meeting +
    1. 2022
    2. 2021
    3. 2020
    4. 2019
    5. 2018
    6. 2017
    7. 2016
    8. 2015
    9. 2014
    10. 2013
    11. 2012
    12. 2011
Contact
  1. Germany
  2. UK
  3. Nordic Countries
  4. Netherlands
Cookie Settings

This website uses cookies.

Some of them are essential and required for running the website. Others improve your user experience and may be activated or deactivated at your discretion.

Accept all Save
Privacy Statement Imprint